The Impact of Diabetes-Related Complications on Preference-Based Measures of Health-Related Quality of Life in Adults with Type I Diabetes
- PMID: 27553209
- PMCID: PMC5046160
- DOI: 10.1177/0272989X16658660
The Impact of Diabetes-Related Complications on Preference-Based Measures of Health-Related Quality of Life in Adults with Type I Diabetes
Abstract
Introduction: This study estimates health-related quality of life (HRQoL) or utility decrements associated with type 1 diabetes mellitus (T1DM) using data from a UK research program on the Dose Adjustment For Normal Eating (DAFNE) education program.
Methods: A wide range of data was collected from 2341 individuals who undertook a DAFNE course in 2009-2012, at baseline and for 2 subsequent years. We use fixed- and random-effects linear models to generate utility estimates for T1DM using different instruments: EQ-5D, SF-6D, and EQ-VAS. We show models with and without controls for HbA1c and depression, which may be endogenous (if, for example, there is reverse causality in operation).
Results: We find strong evidence of an unobserved individual effect, suggesting the superiority of the fixed-effects model. Depression shows the greatest decrement across all the models in the preferred fixed-effects model. The fixed-effects EQ-5D model also finds a significant decrement from retinopathy, body mass index, and HbA1c (%). Estimating a decrement using the fixed-effects model is not possible for some conditions where there are few new cases. In the random-effects model, diabetic foot disease shows substantial utility decrements, yet these are not significant in the fixed-effects models.
Conclusion: Utility decrements have been calculated for a wide variety of health states in T1DM that can be used in economic analyses. However, despite the large data set, the low incidence of several complications leads to uncertainty in calculating the utility weights. Depression and diabetic foot disease result in a substantial loss in HRQoL for patients with T1DM. HbA1c (%) appears to have an independent negative impact on HRQoL, although concerns remain regarding the potential endogeneity of this variable.
Keywords: EQ-5D; EQ-VAS; HbA1c; SF-6D; T1DM; depression; health-related quality of life; type 1 diabetes; utility.
© The Author(s) 2016.
Similar articles
-
Health-related quality of life in type 1 diabetes mellitus pediatric patients and their caregivers in Spain: an observational cross-sectional study.Curr Med Res Opin. 2019 Sep;35(9):1589-1595. doi: 10.1080/03007995.2019.1605158. Epub 2019 May 20. Curr Med Res Opin. 2019. PMID: 30964364
-
Measurement Properties of the Online EuroQol-5D-Youth Instrument in Children and Adolescents With Type 1 Diabetes Mellitus: Questionnaire Study.J Med Internet Res. 2019 Nov 12;21(11):e14947. doi: 10.2196/14947. J Med Internet Res. 2019. PMID: 31714252 Free PMC article.
-
Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the SHIELD longitudinal study.Health Qual Life Outcomes. 2012 Aug 21;10:99. doi: 10.1186/1477-7525-10-99. Health Qual Life Outcomes. 2012. PMID: 22917219 Free PMC article.
-
Utility scores for different health states related to depression: individual participant data analysis.Qual Life Res. 2017 Jul;26(7):1649-1658. doi: 10.1007/s11136-017-1536-2. Epub 2017 Mar 4. Qual Life Res. 2017. PMID: 28260149 Free PMC article. Review.
-
A review of the psychometric properties of generic utility measures in multiple sclerosis.Pharmacoeconomics. 2014 Aug;32(8):759-73. doi: 10.1007/s40273-014-0167-5. Pharmacoeconomics. 2014. PMID: 24846760 Review.
Cited by
-
Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trial.Clin Kidney J. 2024 Feb 9;17(2):sfae025. doi: 10.1093/ckj/sfae025. eCollection 2024 Feb. Clin Kidney J. 2024. PMID: 38389710 Free PMC article.
-
Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.Health Technol Assess. 2020 Jun;24(28):1-232. doi: 10.3310/hta24280. Health Technol Assess. 2020. PMID: 32568666 Free PMC article.
-
Population-Wide Screening for Chronic Kidney Disease : A Cost-Effectiveness Analysis.Ann Intern Med. 2023 Jun;176(6):788-797. doi: 10.7326/M22-3228. Epub 2023 May 23. Ann Intern Med. 2023. PMID: 37216661 Free PMC article. Clinical Trial.
-
Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States.J Manag Care Spec Pharm. 2023 Jul;29(7):807-817. doi: 10.18553/jmcp.2023.22331. Epub 2023 May 3. J Manag Care Spec Pharm. 2023. PMID: 37133431 Free PMC article.
-
A cost-utility analysis of long-acting insulin analogues (detemir, glargine and degludec) for the treatment of adult type 1 diabetes in South Africa.Cost Eff Resour Alloc. 2025 Mar 23;23(1):9. doi: 10.1186/s12962-025-00615-x. Cost Eff Resour Alloc. 2025. PMID: 40122825 Free PMC article.
References
-
- Hahl J, Hämäläinen H, Sintonen H, Simell T, Arinen S, Simell O. Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications. Qual Life Res. 2002;11(5):427–36. - PubMed
-
- Ahola AJ, Saraheimo M, Forsblom C, Hietala K, Sintonen H, Groop PH; FinnDiane Study Group. Health-related quality of life in patients with type 1 diabetes—association with diabetic complications (the FinnDiane Study). Nephrol Dial Transplant. 2010;25(6):1903–8. - PubMed
-
- Coffey JT, Brandle M, Zhou H, et al. Valuing health-related quality of life in diabetes. Diabetes Care. 2002;25(12):2238–43. - PubMed
-
- Tabaei BP, Shill-Novak J, Brandle M, Burke R, Kaplan RM, Herman WH. Glycemia and the quality of well-being in patients with diabetes. Qual Life Res. 2004;13:1153–61. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical